Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eurobio ScientificXPAR:ALERS +1.93%68 OCF Margin % is 15.37% as of Dec. 2025, which is 40% above its 10-year median of 11.00. GuruFocus rates XPAR:ALERS with a GF Score™ of 68/100 and a GF Value™ of €25.28 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Eurobio Scientific ranks better than 61.23% on this metric.
The historical rank and industry rank for Eurobio Scientific's OCF Margin % or its related term are showing as below:
XPAR:ALERS'
s OCF Margin % Range Over the Past 10 Years
Min: -11.71 Med: 11 Max: 35.69
Current: 11.18
During the past 13 years, the highest OCF Margin % of Eurobio Scientific was 35.69%. The lowest was -11.71%. And the median was 11.00%.
XPAR:ALERS's OCF Margin % is ranked better than 61.23% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.75
vs XPAR:ALERS: 11.18
The historical data trend for Eurobio Scientific's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALERS vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Eurobio Scientific's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurobio Scientific OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Eurobio Scientific's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurobio Scientific (XPAR:ALERS) has a OCF Margin % of 15.37% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eurobio Scientific and its competitors. This is 40% above median its historical median of 11.00. According to the industry distribution chart, Eurobio Scientific ranks #316 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 38.8%.
Is Eurobio Scientific's OCF Margin % too high?
Eurobio Scientific's current OCF Margin % of 15.37% is 40% above median its 10-year median of 11.00. The Medical Devices & Instruments industry median OCF Margin % is 5.75. Eurobio Scientific's value of 15.37% is 167.3% above this industry median. Based on the distribution chart, Eurobio Scientific ranks #316 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eurobio Scientific has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eurobio Scientific's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eurobio Scientific ranks #316 out of 815 companies for OCF Margin %. This puts Eurobio Scientific in the upper half of its industry. The industry median OCF Margin % is 5.75. Eurobio Scientific's value of 15.37% is 167.3% above this benchmark. While the company's 10-year median is 11.00 vs. the industry median of 5.75, Eurobio Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.75, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurobio Scientific's current OCF Margin % of 15.37% is 167.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eurobio Scientific and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurobio Scientific's current OCF Margin % is 15.37%, which is 40% above median its own 10-year median of 11.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurobio Scientific stock overvalued right now?
Based on GuruFocus' analysis, Eurobio Scientific (XPAR:ALERS) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.28, compared to a current price of €21.10 — trading 16.5% below its estimated fair value. The current OCF Margin % is 15.37%, which is 40% above median its 10-year median of 11.00 and 167.3% above the Medical Devices & Instruments industry median of 5.75. Eurobio Scientific's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Eurobio Scientific (XPAR:ALERS), the current OCF Margin % is 15.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurobio Scientific (XPAR:ALERS) Overvalued in 2026?
Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued.
The current stock price of €21.10 is trading 16.5% below its estimated GF Value™ of €25.28.
GuruFocus considers Eurobio Scientific to be Modestly Undervalued.
Key valuation signals for XPAR:ALERS:
OCF Margin %: 15.37% (40% above median its 10-year median of 11.00)
GF Value™: €25.28 vs. price of €21.10 (16.5% below fair value)
Industry Position: 167.3% above the Medical Devices & Instruments median (#316 of 815)
No single metric tells the full story. See the XPAR:ALERS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
68GF Score
Get the complete analysis for XPAR:ALERS
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALERS has been successfully added to your 
